We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Check the tariff classification for a heat and moisture exchanging filter.
Check the tariff classification for flavour pods.
Information on hydrogen fluoride and hydrofluoric acid, for use in responding to chemical incidents.
The characteristics, diagnosis, management, surveillance and epidemiology of Pseudomonas aeruginosa.
Information to support your recovery after COVID-19.
Check the tariff classification for dried peas processed as pea flour.
Check the tariff classification for peptide nisin standardised with sodium chloride
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
List of Field Safety Notices from 22 to 26 April 2024.
A list of all F gases and their global warming potentials.
Check the tariff classification for components in sets for dental repair.
Check the tariff classification for surface-active preparation for washing the skin and the hair (gel 2-in-1).
The MHRA has authorised cabotegravir as 30 mg tablets and as a 600 mg long-acting injection administered every two months
Get help to classify herbal medicines, vitamins, food preparations, supplements and tonics for import and export.
Work out the toxic equivalency factors of polychlorinated dibenzo-p-dioxins (PCDDs) and polychlorinated dibenzofurans (PCDFs) to calculate their concentration.
Information for clinicians on diagnosis and notification of Shiga toxin-producing Escherichia coli (STEC) and haemolytic uraemic syndrome (HUS).
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.